Medication-Assisted Treatment for Opioid-Use Disorder.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31543255.
- Also identified by DOI 10.1016/j.mayocp.2019.03.029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The United States is in the midst of a national opioid epidemic. Physicians are encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 Food and Drug Administration-approved medications to treat OUD (methadone, buprenorphine, and naltrexone) and there is ample evidence of their efficacy, they are not used as often as they should. We provide a brief review of the 3 primary medications used in the treatment of OUD. Using data from available medical literature, we synthesize existing knowledge and provide a framework for how to determine the optimal approach for outpatient management of OUD with medication-assisted treatments.
Medical subject headings
- Buprenorphine
- Methadone
- Naltrexone
- Opiate Substitution Treatment
- Opioid-Related Disorders